Robert Portman insider trades: Pacifichealth Laboratories (PHLI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2011 | PHLI | ↑ Buy | 400,000 | $0.25 | $100K | Direct | May 13, 2011 (2d) |
| Mar 22, 2011 | PHLI | ↑ Buy | 380,000 | $0.25 | $95K | Direct | Mar 23, 2011 (1d) |
| Aug 20, 2009 | PHLI | ↓ Sell | 150,000 | $0.31 | $47K | Direct | Aug 21, 2009 (1d) |
| Jul 11, 2008 | PHLI | ↑ Buy | 51,000 | $0.31 | $16K | Direct | Jul 18, 2008 (7d) |
| Dec 7, 2007 | PHLI | ↑ Buy | 5,000 | $0.68 | $3K | Direct | Dec 10, 2007 (3d) |
| Dec 5, 2007 | PHLI | ↑ Buy | 15,000 | $0.74 | $11K | Direct | Dec 6, 2007 (1d) |
| Jan 5, 2007 | PHLI | ↑ Buy | 100,000 | $0.95 | $95K | Direct | Jan 8, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert Portman's insider trades
Robert Portman is a director at Pacifichealth Laboratories (PHLI). Since Jan 5, 2007, Robert has reported 6 open-market purchases worth $320K and 1 sale worth $47K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), other transactions (2 filings), gifts (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHLI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.